The Lung Cancer SPORE Biostatistics and Informatics Core provides support in the areas of biostatistics,clinical informatics, and bioinformatics to SPORE investigators. This consultative and collaborative supportis designed to increase the speed and efficiency with which lung cancer research is translated from the labto the clinic. The Core is designed to provide support in study design, data management, data analysis,clinical informatics system creation, bioinformatics data management and interpretation. The Biostatisticsgroup assists primarily with study and protocol design, and data analysis and interpretation. TheInformatics group assists with data quality control, data sharing, designing and maintaining the SPOREdatabase that captures clinical, pathologic, and laboratory data into a relational database. This group alsodesigned the barcode system for collection and storage of all samples. The Bioinformatics group assistswith computational evaluations of large databases, especially those created with genomic and proteomicanalysis using gene expression and SNP arrays and proteomic profiles. All Core members participate inpreparation of reports, presentations, and manuscripts. In addition to these services, Core members willcontinue their efforts to develop new approaches to improve the efficiency and outcomes of the process oftranslational research.Biostatistics and Informatics Core members will assist SPORE investigators in the following areas:1. Experimental design. Design of both pre-clinical and clinical experiments that can provide usefulanswers to scientific questions of importance in lung cancer.2. Data collection/storage/retrieval/sharing: Creation and maintenance of a sound and user-friendlyinfrastructure for data collection, storage, quality assurance, retrieval, and sharing in support ofSPORE trials and tissue banking.3. Data analysis and manuscript preparation: Structuring of data analyses to provide clear answers toquestions, and to communicate those findings in reports and papers.4. Translational research methodology: Development and implementation of coherent methods thatimprove the efficiency and effectiveness of research across the wide spectrum from pre-clinicalresearch to clinical studies, including work in the development of better understanding of the causesof lung cancer, early detection of lung cancer, biomarkers of lung cancer risk, and lung cancer therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA058187-14
Application #
7448831
Study Section
Special Emphasis Panel (ZCA1-GRB-I (J1))
Project Start
2008-05-01
Project End
2013-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
14
Fiscal Year
2008
Total Cost
$174,290
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Tippimanchai, Darinee D; Nolan, Kyle; Poczobutt, Joanna et al. (2018) Adenoviral vectors transduce alveolar macrophages in lung cancer models. Oncoimmunology 7:e1438105
DeHart, David N; Lemasters, John J; Maldonado, Eduardo N (2018) Erastin-Like Anti-Warburg Agents Prevent Mitochondrial Depolarization Induced by Free Tubulin and Decrease Lactate Formation in Cancer Cells. SLAS Discov 23:23-33
Ren, Shengxiang; Zhang, Shucai; Jiang, Tao et al. (2018) Early detection of lung cancer by using an autoantibody panel in Chinese population. Oncoimmunology 7:e1384108
Davies, Kurtis D; Le, Anh T; Sheren, Jamie et al. (2018) Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples. J Thorac Oncol 13:1474-1482
Iams, Wade T; Yu, Hui; Shyr, Yu et al. (2018) First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance. Clin Lung Cancer 19:531-543
McDaniel, Nellie K; Cummings, Christopher T; Iida, Mari et al. (2018) MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. Mol Cancer Ther 17:2297-2308
Ghosh, Moumita; Miller, York E; Vandivier, R William et al. (2018) Reply to Sohal: Airway Basal Cell Reprogramming and Epithelial-Mesenchymal Transition: A Potential Key to Understanding Early Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:1645-1646
Ghosh, Moumita; Miller, York E; Nakachi, Ichiro et al. (2018) Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:885-896
Farago, Anna F; Taylor, Martin S; Doebele, Robert C et al. (2018) Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion. JCO Precis Oncol 2018:
He, Yayi; Liu, Sangtian; Mattei, Jane et al. (2018) The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC. Drug Des Devel Ther 12:981-986

Showing the most recent 10 out of 435 publications